David König
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- CAR-T cell therapy research
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 17
- Cancer Immunotherapy and Biomarkers 7
- Colorectal Cancer Treatments and Studies 4
- Lung Cancer Research Studies 4
- CAR-T cell therapy research 3
-
- Lung Cancer Treatments and Mutations 8
- Lung Cancer Diagnosis and Treatment 4
- Brain Metastases and Treatment 3
- Co-authors
- Heinz Läubli (9 shared papers)Sacha I. Rothschild (9 shared papers)Spasenija Savic Prince (3 shared papers)Alfred Zippelius (4 shared papers)Jarushka Naidoo (1 shared paper)Till Wallrabenstein (2 shared papers)Laura C. Cappelli (1 shared paper)Michal A. Stanczak (1 shared paper)
- Journals
- Lung Cancer (4 papers)Annals of Oncology (3 papers)Journal of Clinical Oncology (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)Pharmacology (2 papers)
- Partner nations
- SwitzerlandGermanySpain
In The Last Decade
David König
21 papers receiving 262 citations
Peers
Comparison fields: 5 of 41
- Oncology 126
- Immunology 57
- Pulmonary and Respiratory Medicine 79
- Cancer Research 23
- Genetics 12
Countries citing papers authored by David König
This map shows the geographic impact of David König's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David König with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David König more than expected).
Fields of papers citing papers by David König
This network shows the impact of papers produced by David König. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David König. The network helps show where David König may publish in the future.
Co-authors
The 25 scholars most cited alongside David König, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 82 | |
| 2 | 2020 | 37 | |
| 3 | 2022 | 35 | |
| 4 | 2024 | 28 | |
| 5 | 2023 | 17 | |
| 6 | 2022 | 14 | |
| 7 | 2021 | 14 | |
| 8 | 2024 | 8 | |
| 9 | 2023 | 7 | |
| 10 | 2020 | 6 | |
| 11 | 2023 | 2 | |
| 12 | 2024 | 2 | |
| 13 | 2023 | 2 | |
| 14 | 2025 | 2 | |
| 15 | 2022 | 2 | |
| 16 | 2024 | 2 | |
| 17 | 2023 | 1 | |
| 18 | 2020 | 1 | |
| 19 | 2025 | 1 | |
| 20 | 2023 | 1 |
About David König
David König is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Immunology and Genetics, having authored 29 papers that have together received 265 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Diagnosis and Treatment (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Lung Cancer Research Studies (4 papers), CAR-T cell therapy research (3 papers), Brain Metastases and Treatment (3 papers) and Cancer-related gene regulation (2 papers). The work is most often cited by research in Oncology (126 citations), Immunology (57 citations), Pulmonary and Respiratory Medicine (79 citations), Cancer Research (23 citations) and Genetics (12 citations). David König has collaborated with scholars based in Switzerland, Germany and Spain. Frequent co-authors include Heinz Läubli, Sacha I. Rothschild, Spasenija Savic Prince, Alfred Zippelius, Jarushka Naidoo, Till Wallrabenstein, Laura C. Cappelli, Michal A. Stanczak, Anne Bärenwaldt and Jinyu Wang. Their work appears in journals such as Lung Cancer, Annals of Oncology, Journal of Clinical Oncology, Journal for ImmunoTherapy of Cancer and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.